Announcements Trials
Browse Landscape

Phase

Phase 2 54Phase NA 30Phase 1/2 30Phase 1 30Phase EARLY_PHASE1 7Phase 3 5Phase 4 3Phase 2/3 3

Status

Completed 35Terminated 15Recruiting 12Withdrawn 7Unknown 6Not yet recruiting 6Active not recruiting 3

Sponsor Class

OTHER 6INDUSTRY 1

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 20Gastrointestinal 18CNS 14Genitourinary 10Thoracic 9Head & Neck 9Tumor-Agnostic 8Gynecologic 8Dermatologic 7Lymphoid 6Sarcoma 5Plasma cell 5Other 4Other hematologic neoplasm 3Other solid neoplasm 2Other neoplasm 1NET 1Myeloid 1Endocrine 1Classical hematology 1

Conditions

Melanoma 3Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Keratosis, Actinic 1Head and Neck Neoplasms 1Carcinoma, Basal Cell 1

Interventions

durvalumab 2tremelimumab 1arsenous acid 1Vorinostat 1Radiotherapy 1Nivolumab 1Itraconazole 1Gene Expression Profiling 1Fluvastatin 1Cryotherapy 1Base Sequence 1Arsenic Trioxide 13-ingenyl angelate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Withdrawn × Dermatologic × Clear all
NCT04891718 2022-07-08

CIVO Intratumoural Microdosing of Anti-Cancer Therapies in Australia

Presage Biosciences

Phase EARLY_PHASE1 Withdrawn
DermatologicHead & NeckLymphoidSarcoma

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Lymphoma, Melanoma, Sarcoma

NCT01735942 2021-12-06

Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions

Northwestern University

Phase EARLY_PHASE1 Withdrawn
Dermatologic

Keratosis, Actinic

NCT04223648 2021-11-22

Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma

Yale University

Phase EARLY_PHASE1 Withdrawn
Dermatologic

Melanoma

NCT02699723 2020-10-22

Arsenic Trioxide and Itraconazole in Treating Patients With Advanced Basal Cell Cancer

Stanford University

Phase EARLY_PHASE1 Withdrawn
Dermatologic

Carcinoma, Basal Cell

NCT04285749 2020-07-27

Prevention of Recurrence and Metastasis in Genetically High-Risk Melanomas

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Withdrawn
Dermatologic

Melanoma

NCT03022565 2020-02-06

Vorinostat in Patients With Class 2 High Risk Uveal Melanoma

University of Miami

Phase EARLY_PHASE1 Withdrawn
Dermatologic

Uveal Melanoma

NCT03235869 2018-03-15

Radiation Therapy Plus Durvalumab for Tumor-Stage Cutaneous T-Cell Lymphoma

University of Michigan Rogel Cancer Center

Phase EARLY_PHASE1 Withdrawn
DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡